The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2185–2208 of 3,535
Reviva Pharmaceuticals Holdings, Inc. has announced significant advancements regarding their clinical-stage drug candidate, **brilaroxazine**, which targets mul...
A recent study from Northwestern University highlights the remarkable cognitive resilience of **SuperAgers**, individuals over 80 who exhibit memory capabilitie...
The Asthma and Allergy Foundation of America (AAFA) has launched the **Patient-Centered Education and Care for Nasal Polyps (PEACE-NP)** program, coinciding wit...
Tonix Pharmaceuticals has announced promising preclinical findings regarding its investigational candidates TNX-1700 and TNX-4700, presented at the AACR Annual...
Transcenta Therapeutics has unveiled promising preclinical data on its **LIV1-targeting antibody-drug conjugates (ADCs)** during the 2026 AACR Annual Meeting. T...
The field of dermatology is experiencing a significant transformation driven by a deeper understanding of the **mechanisms of aging** and the advent of effectiv...
Recent research highlights the **superior DNA repair mechanisms** in bowhead whales, contributing to their remarkable longevity and low cancer incidence. This s...
Researchers at McGill University and the Douglas Institute have identified **two specific types of brain cells** that exhibit altered behavior in individuals wi...
ENA Respiratory has appointed **Melissa Faris** as an independent Non-Executive Director, bringing extensive experience from her roles at OMass Therapeutics and...
Merck and Eisai have announced that the Phase 3 LITESPARK-012 trial, designed to evaluate the efficacy of novel treatment combinations for advanced clear cell r...
Flagship Pioneering has unveiled **Serif Biomedicines**, a new venture aimed at revolutionizing therapeutics through **Modified DNA**, a novel class of medicine...
Rznomics unveiled promising interim clinical data for **RZ-001** during the AACR 2026 conference, showcasing its efficacy in treating **hepatocellular carcinoma...
Innovative Vitality has launched a new membership program, **Longevity Labs & Provider Review**, aimed at enhancing personalized health optimization through adv...
A recent study presented at Digestive Disease Week 2026 highlights the potential of **duodenal mucosal resurfacing** (DMR) as a minimally invasive procedure to...
Santhera Pharmaceuticals has announced the appointment of **Orlando Oliveira** as its new Chief Executive Officer, effective **July 15, 2026**, succeeding **Dar...
Dr. Bruce Lahn and his team at VectorBuilder have unveiled a pivotal mechanism in developmental biology through their innovative technique, **Potency-Seq**, whi...
Santhera Pharmaceuticals has announced the appointment of **Orlando Oliveira** as the new Chief Executive Officer (CEO), effective **July 15, 2026**, succeeding...
Dr. Bruce Lahn and his team at VectorBuilder have unveiled a groundbreaking technique, **Potency-Seq**, which measures the transcriptional potential of genes, s...
Researchers at RMIT University have developed a novel **virus-fighting plastic film** that effectively destroys viruses on contact through a mechanical mechanis...
Researchers at the University of California, Irvine, have identified a method to potentially reverse age-related vision loss by targeting the **ELOVL2 aging gen...
The U.S. Food and Drug Administration (FDA) has approved **Dupixent® (dupilumab)** for the treatment of children aged 2 to 11 years with **chronic spontaneous u...
The **TRIDENT trial**, led by George Medicines, has demonstrated that the **GMRx2** combination therapy (telmisartan, amlodipine, and indapamide) significantly...
Abivax SA is set to present nine scientific abstracts on **obefazimod**, its lead drug candidate for treating moderately to severely active ulcerative colitis (...
BridgeBio Oncology Therapeutics (BBOT) has unveiled promising preclinical data for **BBO-11818**, a selective, orally bioavailable **non-covalent inhibitor** ta...
